drugset / Trial / NCT03080298

Study of the Efficacy and Safety of BP101 in Female Patients With Decrease or Loss of Sexual Desire

NCT03080298 ↗

Phase 2 Completed 119 enrolled Ivix LLX
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is study of the efficacy, safety and pharmacokinetics of BP101 compared to placebo in patients with a decrease or loss of sexual desire.

Timeline

Start
2016-03-14
Primary completion
2017-04-04
Completion
2017-07-25

Drugs

EvaluationDrugModalityDoseRoute
Subject BP101 Unknown — —